CHRISTOPHER FORBES Insider Trading $ELOX Eloxx Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CHRISTOPHER FORBES.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CHRISTOPHER FORBES. CHRISTOPHER FORBES is Director in Sevion Therapeutics, Inc. ($SVON).

CHRISTOPHER FORBES in Eloxx Pharmaceuticals, Inc.

Trading Symbol: ELOX
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of CHRISTOPHER FORBES: Director
Holdings: 7,452,289 shares
Current Value: $1,714,026
Latest Transaction: May 19 2011
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of CHRISTOPHER FORBES in Eloxx Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 19 2011	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.30	37,962	11,389	741,239
Mar 23 2011	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.28	15,000	4,191	7,452,289	7.4 M to 7.5 M (+0.20 %)
Feb 16 2011	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.32	32,758	10,483	703,277
Nov 19 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.29	67,308	19,519	670,519
Nov 19 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.29	125,000	36,250	603,211
Jun 03 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	P	0.32	1,000	320	1,000
Jun 03 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	P	0.35	3,125,000	1,093,750	7,091,477
May 27 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	C	0.83	4,101,800	3,404,494	7,407,289	3.3 M to 7.4 M (+124.09 %)
May 27 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Grant	A	0.51	78,469	40,294	3,305,489	3.2 M to 3.3 M (+2.43 %)
May 27 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Grant	A	0.37	182,840	67,157	3,227,020	3 M to 3.2 M (+6.01 %)
May 24 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.67	19,262	12,906	478,211
Feb 23 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.32	54,166	17,333	458,949
Feb 23 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	P	0.83	567,416	470,955	3,966,477
Feb 23 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	P	0.83	851,123	706,432	3,399,061
Feb 23 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	P	1.01	567,416	573,090	2,547,938
Feb 23 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	P	1.01	851,123	859,634	1,980,522
Feb 23 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	P	1.01	510,676	515,783	1,129,399
Feb 23 2010	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.00	882,381	0	3,044,180	2.2 M to 3 M (+40.82 %)
Nov 23 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.43	40,000	17,200	404,783
Nov 23 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.43	48,718	20,949	364,783
Nov 23 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.65	18,077	11,750	316,065
Jul 31 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.00	89,222	0	618,723	529.5 K to 618.7 K (+16.85 %)
Jul 31 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.00	88,000	0	529,501	441.5 K to 529.5 K (+19.93 %)
Jul 31 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.90	97,778	88,000	2,191,799	2.1 M to 2.2 M (+4.67 %)
Mar 17 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.51	200	102	2,094,021	2.1 M to 2.1 M (+0.01 %)
Mar 17 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.49	2,300	1,127	2,093,821	2.1 M to 2.1 M (+0.11 %)
Mar 17 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.46	2,300	1,058	2,091,521	2.1 M to 2.1 M (+0.11 %)
Mar 16 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.39	10,200	3,978	2,089,221	2.1 M to 2.1 M (+0.49 %)
Mar 16 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.36	2,000	720	2,079,021	2.1 M to 2.1 M (+0.10 %)
Mar 11 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.37	2,500	925	2,077,021	2.1 M to 2.1 M (+0.12 %)
Mar 11 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.38	10,000	3,800	2,074,521	2.1 M to 2.1 M (+0.48 %)
Mar 06 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.40	1,000	400	2,064,521	2.1 M to 2.1 M (+0.05 %)
Mar 06 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.38	2,000	760	2,063,521	2.1 M to 2.1 M (+0.10 %)
Mar 06 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.40	5,500	2,200	2,061,521	2.1 M to 2.1 M (+0.27 %)
Mar 04 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.40	1,200	480	2,056,021	2.1 M to 2.1 M (+0.06 %)
Mar 04 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.39	3,000	1,170	2,054,821	2.1 M to 2.1 M (+0.15 %)
Mar 04 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.37	2,800	1,036	2,051,821	2 M to 2.1 M (+0.14 %)
Mar 02 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.39	2,000	780	2,049,021	2 M to 2 M (+0.10 %)
Mar 02 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.40	3,000	1,200	2,047,021	2 M to 2 M (+0.15 %)
Mar 02 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.40	4,000	1,600	2,044,021	2 M to 2 M (+0.20 %)
Feb 24 2009	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.52	23,404	12,170	337,988
Dec 17 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.70	2,000	1,400	2,040,021	2 M to 2 M (+0.10 %)
Dec 17 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.74	2,000	1,480	2,040,021	2 M to 2 M (+0.10 %)
Dec 16 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.70	3,000	2,100	2,036,021	2 M to 2 M (+0.15 %)
Dec 16 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.61	2,900	1,769	2,036,021	2 M to 2 M (+0.14 %)
Dec 16 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.60	100	60	2,036,021	2 M to 2 M (0.00 %)
Dec 16 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Buy	P	0.60	4,000	2,400	2,036,021	2 M to 2 M (+0.20 %)
Nov 21 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.66	50,000	33,000	300,000
Nov 21 2008	SVON	Sevion Therapeutic ...	FORBES CHRISTOPHER	Director	Option Exercise	A	0.66	14,584	9,625	314,584

Page: 1